Vikas Kumar

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

Biomolecules

Journal of molecular modeling

Gyeongsang National University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Gyeongsang National University Mar 04 2019

South Korea

PHD :: APPLIED LIFE SCIENCES

Himachal Pradesh University Jun 01 2012 - Jun 30 2014

India

MSC :: MICROBIOLOGY

Publications

Pooja Singh, Vikas Kumar, Tae Sung Jung, Jeong Sang Lee, Keun Woo Lee, Jong Chan Hong
Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations. Journal of molecular modeling 30 (8) (2024)
Pooja Singh, Vikas Kumar, Keun Woo Lee, Jong Chan Hong
Discovery of Novel Allosteric SHP2 Inhibitor Using Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Principal Component Analysis. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Pooja Singh, Vikas Kumar, Keun Woo Lee, Jong Chan Hong
Discovery of Novel Allosteric SHP2 Inhibitor Using Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Principal Component Analysis. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Pooja Singh, Vikas Kumar, Tae Sung Jung, Jeong Sang Lee, Keun Woo Lee, Jong Chan Hong
Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations. Journal of molecular modeling 30 (8) (2024)
Pooja Singh, Vikas Kumar, Tae Sung Jung, Jeong Sang Lee, Keun Woo Lee, Jong Chan Hong
Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations. Journal of molecular modeling 30 (8) (2024)
Pooja Singh, Vikas Kumar, Keun Woo Lee, Jong Chan Hong
Discovery of Novel Allosteric SHP2 Inhibitor Using Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Principal Component Analysis. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Abu Jubayer Hossain, Rokibul Islam, Jong-Bok Seo, Hwee-Seon Park, Jong-Il Kim, Vikas Kumar, Keun Woo Lee, Jae-Bong Park
Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin. International journal of molecular sciences 24 (18) (2023)
Vikas Kumar, Raj Kumar, Shraddha Parate, null Danishuddin, Gihwan Lee, Moonhyuk Kwon, Seong-Hee Jeong, Hyeon-Su Ro, Keun Woo Lee, Seon-Won Kim
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules 13 (2) (2023)
Gunjan Thakur, Vikas Kumar, Keun Woo Lee, Chungkil Won
Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade. Genes 13 (8) (2022)
Pooja Singh, Vikas Kumar, Gihwan Lee, Tae Sung Jung, Min-Woo Ha, Jong Chan Hong, Keun Woo Lee
Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry. International journal of molecular sciences 23 (24) (2022)
Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee
Investigating natural compounds against oncogenic RET tyrosine kinase using pharmacoinformatic approaches for cancer therapeutics. RSC advances 12 (2) (2022)
Apoorva M Kulkarni, Vikas Kumar, Shraddha Parate, Gihwan Lee, Sanghwa Yoon, Keun Woo Lee
Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods. International journal of molecular sciences 23 (3) (2022)
Pooja Singh, Vikas Kumar, Gihwan Lee, Tae Sung Jung, Min-Woo Ha, Jong Chan Hong, Keun Woo Lee
Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry. International journal of molecular sciences 23 (24) (2022)
Pooja Singh, Vikas Kumar, Gihwan Lee, Tae Sung Jung, Min-Woo Ha, Jong Chan Hong, Keun Woo Lee
Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry. International journal of molecular sciences 23 (24) (2022)
Pooja Singh, Vikas Kumar, Gihwan Lee, Tae Sung Jung, Min-Woo Ha, Jong Chan Hong, Keun Woo Lee
Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry. International journal of molecular sciences 23 (24) (2022)
Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee
Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands. Marine drugs 19 (10) (2021)
Shraddha Parate, Vikas Kumar, Gihwan Lee, Shailima Rampogu, Jong Chan Hong, Keun Woo Lee
Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Shraddha Parate, Vikas Kumar, null Danishuddin, Jong Chan Hong, Keun Woo Lee
Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics. International journal of molecular sciences 22 (10) (2021)
Vikas Kumar, Shraddha Parate, Gunjan Thakur, Gihwan Lee, Hyeon-Su Ro, Yongseong Kim, Hong Ja Kim, Myeong Ok Kim, Keun Woo Lee
Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations. Biomedicines 9 (9) (2021)
Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee
Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics. Molecules (Basel, Switzerland) 26 (8) (2021)
null Danishuddin, Vikas Kumar, Shraddha Parate, Ashutosh Bahuguna, Gihwan Lee, Myeong Ok Kim, Keun Woo Lee
Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Sagar Barage, A Karthic, Rohit Bavi, Neetin Desai, Raj Kumar, Vikas Kumar, Keun Woo Lee
Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach. Journal of biomolecular structure & dynamics (2020)

Vikas Kumar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vikas Kumar